tiprankstipranks
Trending News
More News >
MBX Biosciences, Inc. (MBX)
NASDAQ:MBX
US Market

MBX Biosciences, Inc. (MBX) Income Statement

Compare
205 Followers

MBX Biosciences, Inc. Income Statement

Last quarter (Q4 2025), MBX Biosciences, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MBX Biosciences, Inc.'s net income was $-22.06M. See MBX Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -248.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 98.06M$ 68.19M$ 35.31M$ 25.16M
Depreciation and Amortization
$ 248.00K$ 244.00K$ 157.00K$ 56.00K
EBITDA
$ -98.06M$ -67.95M$ -35.15M$ -25.70M
Operating Income
$ -98.06M$ -68.19M$ -35.31M$ -25.16M
Other Income/Expenses
$ 11.08M$ 6.27M$ 2.75M$ -974.00K
Pretax Income
$ -86.97M$ -61.92M$ -32.56M$ -26.14M
Net Income
$ -86.97M$ -61.92M$ -32.56M$ -26.14M
Per Share Metrics
Basic EPS
$ -2.38$ -1.85$ -1.02$ -0.82
Diluted EPS
$ -2.38$ -1.85$ -1.02$ -0.82
Weighted Average Shares Outstanding
36.51M 33.39M 31.85M 31.85M
Weighted Average Shares Outstanding (Diluted)
36.51M 33.39M 31.85M 31.85M
Currency in USD

MBX Biosciences, Inc. Earnings and Revenue History